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Background: Acute rheumatic fever (ARF) is an autoreactive disease secondary to a group A streptococcal infection involving the heart, joints, skin 
and brain. During an infection activated antigen presenting cells present the bacterial antigen to helper T cells, which subsequently activate B cells 
and induce the production of antibodies against the cell wall of streptococcus. These antibodies also react against the myocardium. The cell wall 
of group A streptococcus pyogenes is composed of branched polymers containing “M proteins” which are highly antigenic and may cross-react with 
cardiac myosin. We focus on heart specific antibodies in sera from patients with rheumatic fever from India and Russia.
Methods: In the Indian series sera from 9 pts with acute rheumatic fever, 17 pts with chronic/rheumatic heart disease (CHD/RHD) and 17 
controls from individuals without heart disease, in the Russian series 56 pts with acute rheumatic heart disease were probed in one- and two-
dimensional Western blots for reactivity against heart tissue antigens, respectively.
Results: Indian series: Antibodies against fragments of the myosin heavy chain were demonstrated in 77% of sera of patients with ARF, in 35% 
of sera of patients with CHD/RHD but not in control sera. Antibodies directed against proteins with a molecular weight of 50kd, 45kd,37 kd and 
to a much lesser extend of 40kd were directed against a lysate of cardiac tissue. Antibodies against 55 kd, 50kd, 45kd proteins from a lysate of 
streptococcus M-protein were not found in controls but in 44 - 77% of patients with ARF and in about 12 - 25 % of cases in CHD/RHD. Russian 
series: Antibodies directed against relevant myocardial antigens were various the following: 80 % of pts sera demonstrated antibodies against 
creatine kinase, 41 % of pts antibodies against dihydrolipoamide dehydrogenase. (p<0,01 chi-square, when compared to age-matched controls). 
Further newly identified antibodies were hsp 73, grp 78 and hsp 60 and aconitate hydratase.
Conclusion: By sequence analysis we could identify several additional myocardial antigens to be involved in the secondary immunopathogenesis 
of ARF and CHD/RHD
